THE TAPE

Exponent Inc

$88.18▲ +1.00%
Last close
Relative strength
90RS
of 99, against every stock▲ +26 on the month
Powering up
Unconfirmed
+53.5%
six months against the S&P 500
52-week range
−2.6%
from the high
$51.91$90.51
Setup
multi yearclimbing
+5.1%
against the pivot at $83.92
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Oct 2, revenue +18% on a year ago
11/16 O 87.82 H 88.72 L 87.60 Vol 341.8K
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS90
vs pivot+5.08%
Tightening0.70×
Dry-up0.70×
Up/down vol0.37
From high3%
climbing6 of 9checks
Powering up
Support and resistance
Support below
$71.46
-19.0% · tested 4× · last 20 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 76.8 weeks and fell 38% from its ceiling at its deepest. The pivot is $83.92, and the stock closed 5.1% above that pivot. Its relative strength rating is 90.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+26.6%
Three months against the S&P 500
+35.5%
Six months against the S&P 500
+53.5%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
18
days
Ex-dividend in 18 days
Dec 4, 2026
  1. Ex-dividendconfirmedin 18d
    Ex-dividend date
    Dec 4, 2026
How it moves on earnings

On average 4.3% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$659.1M
+18.1% year on year
Operating margin
21.3%
Net margin
17.4%
Free cash flow
$140.6M
3.4% of market cap
Price to sales
6.36×
Price to earnings
36.6×

Twelve months to Oct 2, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 29
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$173.7M
+1.2% QoQ · +18.1% YoY
Gross margin
—
Net income
$30.9M
Positive
Free cash flow
$62.1M
Cash generating

What the numbers say

  • Revenue +18.1% year over year, +1.2% on the quarter
  • Good: Profitable: net income $31M, operating margin 24.1%
  • Good: Cash generating: operating cash flow $63M, free cash flow $62M
  • Good: Share count -5.4% in a year: buying back
  • Good: Net cash $115M · cash $115M
Revenue by quarter
Free cash flow
Net income
shares -5.4% in a year · net cash $114.7M
Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

No tracked fund holds it now at the end of Q3 2026.

Last quarter: 2 sold out.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Tightening after a sharp runTape · 2026-11-13
range halved after a +20% thrust, at 86.22
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
GappedTape · 2026-11-03
+7.9%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Reported resultsFiling · 2026-10-30
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Earnings comingEvent · 2026-10-28
reports 2026-10-29 amc
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Moved 5%+ up on earningsTape · 2026-10-23
+5.4% on earnings 2026-10-22
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
GappedTape · 2026-10-22
+5.4%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Unusual volumeTape · 2026-09-19
7.5 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Unusual volumeTape · 2026-09-16
8.2 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news

No headlines for this company in the last couple of weeks.

Insiders
Bought on the open market
1
$12,594 total
Sold on the open market
6
$683,057 total

Bought: Souri Shukri Jeries. Sold: Reiss Richard, Corrigan Catherine, James Bradley A.

Not counted above: 11 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-11-03 Reiss Richard · Group Vice Presidentsell1,280$110,643
2026-09-18 Souri Shukri Jeries · Group Vice Presidentbuy184$12,594
2026-08-17 Corrigan Catherine · Chief Executive Officer, Directoroption exercise2,379$69,110
2026-08-17 Corrigan Catherine · Chief Executive Officer, Directorsell1,707$113,136
2026-07-28 Corrigan Catherine · Chief Executive Officer, Directoroption exercise12,665$474,304
2026-07-15 Corrigan Catherine · Chief Executive Officer, Directoroption exercise2,379$69,110
2026-07-15 Corrigan Catherine · Chief Executive Officer, Directorsell1,737$109,045
2026-06-25 Corrigan Catherine · Chief Executive Officer, Directoroption exercise7,872$199,988

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

6 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy1
Buy2
Hold1
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Exponent Inc (EXPO) — The Tape